Personalized antisense oligonucleotide (CHCHD10)

· n-Lorem Foundation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Personalized antisense oligonucleotide (CHCHD10), covering 2025-07-31 to 2025-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS [Phase 1, Phase 2]